Double-Expressor Lymphoma
8 clinical trials · Condition
◉ Watch Double-Expressor Lymphoma
| Record | Firm | Date |
|---|---|---|
| Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma (NCT04479267) | Barbara Ann Karmanos Cancer Institute | 2020-08-21 |
| Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas (NCT03984448) | National Cancer Institute (NCI) | 2019-10-22 |
| Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients (NCT04164368) | Fudan University | 2019-10-22 |
Track Double-Expressor Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.